Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | BCRX |
---|---|---|
09:32 ET | 100062 | 4.9 |
09:34 ET | 20097 | 4.935 |
09:36 ET | 8081 | 4.935 |
09:38 ET | 7100 | 4.935 |
09:39 ET | 39907 | 4.91 |
09:41 ET | 8109 | 4.93 |
09:43 ET | 11162 | 4.945 |
09:45 ET | 13705 | 4.925 |
09:48 ET | 7331 | 4.93 |
09:50 ET | 14925 | 4.935 |
09:52 ET | 14975 | 4.945 |
09:54 ET | 22801 | 4.955 |
09:56 ET | 4171 | 4.945 |
09:57 ET | 5900 | 4.955 |
09:59 ET | 27548 | 4.965 |
10:01 ET | 42738 | 5.01 |
10:03 ET | 18968 | 5.01 |
10:06 ET | 14078 | 4.99 |
10:08 ET | 3707 | 5.015 |
10:10 ET | 18567 | 5.0209 |
10:12 ET | 31999 | 5.015 |
10:14 ET | 22836 | 5 |
10:15 ET | 11999 | 5.01 |
10:17 ET | 4484 | 5.025 |
10:19 ET | 8914 | 5.025 |
10:21 ET | 40593 | 5.005 |
10:24 ET | 5762 | 5.005 |
10:26 ET | 6360 | 4.995 |
10:28 ET | 18623 | 4.99 |
10:30 ET | 15533 | 4.985 |
10:32 ET | 5075 | 4.99 |
10:33 ET | 9622 | 5.015 |
10:35 ET | 21900 | 5.005 |
10:37 ET | 9775 | 5.03 |
10:39 ET | 1875 | 5.03 |
10:42 ET | 12680 | 5.025 |
10:44 ET | 2954 | 5.015 |
10:46 ET | 13751 | 5.02 |
10:48 ET | 1142 | 5.03 |
10:50 ET | 28288 | 5.035 |
10:51 ET | 2518 | 5.04 |
10:53 ET | 6075 | 5.05 |
10:55 ET | 13826 | 5.0695 |
10:57 ET | 19458 | 5.075 |
11:00 ET | 8355 | 5.0825 |
11:02 ET | 4688 | 5.09 |
11:04 ET | 13819 | 5.075 |
11:06 ET | 9421 | 5.075 |
11:08 ET | 2383 | 5.075 |
11:09 ET | 26255 | 5.085 |
11:11 ET | 15126 | 5.075 |
11:13 ET | 5005 | 5.07 |
11:15 ET | 12252 | 5.085 |
11:18 ET | 5231 | 5.075 |
11:20 ET | 7299 | 5.055 |
11:22 ET | 17225 | 5.05 |
11:24 ET | 4000 | 5.035 |
11:26 ET | 7574 | 5.04 |
11:27 ET | 12400 | 5.035 |
11:29 ET | 3476 | 5.05 |
11:31 ET | 7747 | 5.03 |
11:33 ET | 1700 | 5.025 |
11:36 ET | 800 | 5.03 |
11:38 ET | 1100 | 5.03 |
11:40 ET | 8098 | 5.03 |
11:42 ET | 45481 | 5.015 |
11:44 ET | 2070 | 5.015 |
11:45 ET | 70747 | 5.005 |
11:47 ET | 15452 | 5 |
11:49 ET | 400 | 5.005 |
11:51 ET | 31576 | 4.995 |
11:54 ET | 12360 | 4.995 |
11:56 ET | 3782 | 4.995 |
11:58 ET | 5695 | 5.005 |
12:00 ET | 20798 | 5.005 |
12:02 ET | 11620 | 5 |
12:03 ET | 9066 | 5.015 |
12:05 ET | 9004 | 5.005 |
12:07 ET | 6281 | 5.005 |
12:09 ET | 1200 | 5.005 |
12:12 ET | 1153 | 5.01 |
12:14 ET | 6567 | 5.015 |
12:16 ET | 2244 | 5.02 |
12:18 ET | 7340 | 5.025 |
12:20 ET | 3513 | 5.03 |
12:21 ET | 44971 | 5.025 |
12:23 ET | 3489 | 5.025 |
12:25 ET | 4896 | 5.03 |
12:27 ET | 4783 | 5.025 |
12:30 ET | 1600 | 5.025 |
12:32 ET | 9766 | 5.025 |
12:34 ET | 800 | 5.025 |
12:36 ET | 1127 | 5.025 |
12:38 ET | 7673 | 5.04 |
12:39 ET | 5843 | 5.045 |
12:41 ET | 3800 | 5.045 |
12:43 ET | 1060 | 5.05 |
12:45 ET | 31553 | 5.045 |
12:48 ET | 1098 | 5.045 |
12:50 ET | 7569 | 5.055 |
12:52 ET | 9020 | 5.055 |
12:54 ET | 10863 | 5.055 |
12:56 ET | 1705 | 5.055 |
12:57 ET | 500 | 5.05 |
12:59 ET | 2262 | 5.06 |
01:01 ET | 34753 | 5.025 |
01:03 ET | 7274 | 5.025 |
01:06 ET | 6291 | 5.03 |
01:08 ET | 1439 | 5.025 |
01:10 ET | 1715 | 5.025 |
01:12 ET | 18685 | 5.025 |
01:15 ET | 14103 | 5.02 |
01:17 ET | 24265 | 5.025 |
01:19 ET | 59851 | 5.04 |
01:21 ET | 6812 | 5.035 |
01:24 ET | 11240 | 5.055 |
01:26 ET | 200 | 5.055 |
01:28 ET | 1201 | 5.06 |
01:30 ET | 585 | 5.06 |
01:32 ET | 3930 | 5.065 |
01:33 ET | 1326 | 5.065 |
01:35 ET | 12365 | 5.075 |
01:37 ET | 10962 | 5.0801 |
01:39 ET | 46907 | 5.085 |
01:42 ET | 25420 | 5.11 |
01:44 ET | 4124 | 5.12 |
01:46 ET | 4270 | 5.12 |
01:48 ET | 2495 | 5.12 |
01:50 ET | 13235 | 5.13 |
01:51 ET | 10984 | 5.15 |
01:53 ET | 20199 | 5.17 |
01:55 ET | 28441 | 5.145 |
01:57 ET | 6010 | 5.14 |
02:00 ET | 800 | 5.145 |
02:02 ET | 8950 | 5.105 |
02:04 ET | 10786 | 5.115 |
02:06 ET | 3906 | 5.105 |
02:08 ET | 3201 | 5.11 |
02:09 ET | 8048 | 5.12 |
02:11 ET | 5686 | 5.12 |
02:13 ET | 6520 | 5.125 |
02:15 ET | 9475 | 5.11 |
02:18 ET | 1395 | 5.11 |
02:20 ET | 6261 | 5.105 |
02:22 ET | 2987 | 5.11 |
02:24 ET | 14491 | 5.105 |
02:26 ET | 1924 | 5.105 |
02:27 ET | 7133 | 5.12 |
02:29 ET | 1458 | 5.12 |
02:31 ET | 20134 | 5.09 |
02:33 ET | 5220 | 5.085 |
02:36 ET | 1200 | 5.085 |
02:38 ET | 4074 | 5.08 |
02:40 ET | 3846 | 5.075 |
02:42 ET | 1400 | 5.075 |
02:44 ET | 10821 | 5.065 |
02:45 ET | 2500 | 5.065 |
02:47 ET | 5087 | 5.06 |
02:49 ET | 13546 | 5.07 |
02:51 ET | 10250 | 5.0601 |
02:54 ET | 3711 | 5.06 |
02:56 ET | 16940 | 5.055 |
02:58 ET | 3806 | 5.07 |
03:00 ET | 28533 | 5.08 |
03:02 ET | 5642 | 5.08 |
03:03 ET | 9259 | 5.065 |
03:05 ET | 1500 | 5.06 |
03:07 ET | 5778 | 5.06 |
03:09 ET | 3621 | 5.065 |
03:12 ET | 7761 | 5.06 |
03:14 ET | 34987 | 5.055 |
03:16 ET | 11405 | 5.06 |
03:18 ET | 17408 | 5.065 |
03:20 ET | 14913 | 5.065 |
03:21 ET | 33470 | 5.07 |
03:23 ET | 28972 | 5.105 |
03:25 ET | 26874 | 5.1 |
03:27 ET | 11006 | 5.095 |
03:30 ET | 2199 | 5.1 |
03:32 ET | 12257 | 5.095 |
03:34 ET | 9738 | 5.095 |
03:36 ET | 24107 | 5.085 |
03:38 ET | 4903 | 5.095 |
03:39 ET | 22657 | 5.085 |
03:41 ET | 39688 | 5.08 |
03:43 ET | 21434 | 5.08 |
03:45 ET | 29591 | 5.075 |
03:48 ET | 32326 | 5.075 |
03:50 ET | 6032 | 5.08 |
03:52 ET | 46484 | 5.08 |
03:54 ET | 31572 | 5.1 |
03:56 ET | 108706 | 5.0801 |
03:57 ET | 89547 | 5.065 |
03:59 ET | 166259 | 5.07 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
BioCryst Pharmaceuticals Inc | 1.0B | -4.3x | --- |
MiMedx Group Inc | 1.2B | 29.2x | --- |
Kiniksa Pharmaceuticals Ltd | 1.4B | 122.4x | --- |
ADMA Biologics Inc | 1.4B | -47.0x | --- |
Veracyte Inc | 1.7B | -21.1x | --- |
CareDx Inc | 512.1M | -2.8x | --- |
BioCryst Pharmaceuticals, Inc. is a commercial-stage biotechnology company that discovers and commercializes oral, small-molecule medicines. The Company focuses on oral treatments for rare diseases, in which unmet medical needs exist and an enzyme plays the key role in the biological pathway of the disease. Its marketed products include oral, once-daily ORLADEYO for the prevention of hereditary angioedema (HAE) attacks and RAPIVAB (peramivir injection) for the treatment of acute uncomplicated influenza in the United States. Its other products and product candidates include BCX10013, RAPIACTA (peramivir injection), BCX9930, BCX9250, PERAMIFLU (peramivir injection), galidesivir, and early-stage discovery programs. BCX10013, is a potent and specific Factor D inhibitor. RAPIACTA focuses on uncomplicated seasonal influenza. BCX9930 is an oral, potent, and selective small molecule inhibitor of Factor D. Galidesivir is a broad-spectrum antiviral that is active against viral families.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.0B |
---|---|
Revenue (TTM) | $331.4M |
Shares Outstanding | 206.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.92 |
EPS | $-1.18 |
Book Value | $-2.21 |
P/E Ratio | -4.3x |
Price/Sales (TTM) | 3.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -40.05% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.